Helix BiopharmaHBP 
$0.975.60%24h
5.60%24h
Global rank17039
Market cap$187.35M
Change 7d0.00%
YTD Performance528.57%
SP500 benchmarkOutperform
P/E-32.32
P/S0
Revenue$0
Earnings-$4.62M
Dividend yield-
Main Sector
Healthcare
EPS for Helix Biopharma (HBP)
Helix Biopharma has an EPS of $-0.03. In 2022, the company made an earnings per share (EPS) of $-0.04. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for HBP
-
Value:-
EPS history for Helix Biopharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.03 | -25.00% |
| 2022 | -$0.04 | -33.33% |
| 2021 | -$0.06 | -14.29% |
| 2020 | -$0.07 | - |
View the highest EPS stocks
